Microsoft (NASDAQ MSFT) have been a stand out stock in the past few months. While few analysts have been looking for a minor correction, most of the market is optimistic about the stock. This is also because of the fact that Microsoft is on the verge of launching Windows 10 Operating System which got a…
U.S. Treasury prices got a bounce on an impressive $21 billion reopened 10-year auction, which saw solid demand across all measures and sent the 10-year into the leader position to slip to the 2.717% yield. The high-yield came in at 2.729% when traders had been looking for a mid-range of 2.74%, indicating buyers were willing…
Jive Software (NASDAQ:JIVE) was initiated with a Buy at B. Riley setting their target price at $17. Jive Software, Inc. (NASDAQ:JIVE) provides a social business software platform. The Company is focused on unlocking the power of the enterprise social graph, which is the extended social network of an enterprise, encompassing relationships among its employees, customers…
Pzifer(NYSE:PFE)’s stock was halted in afternoon trade following the announcement that the United States District Court for the Eastern District of Virginia granted summary judgment invalidating the reissue patent (U.S. Patent No. RE44,048), covering methods of treating osteoarthritis and other approved conditions with celecoxib, the active ingredient in Celebrex®. Pfizer (PFE) disagrees with the ruling and will…
The Blackberry Ltd (NASDAQ:BBRY) Township Board on Tuesday selected a successor for its vacant township supervisor position. BlackBerry Ltd (NASDAQ:BBRY) stock performance was -3.72% in last session and finished the day at $9.31. Traded volume was 16,214,110 million shares in the last session and the average volume of the stock remained 28.84 million shares. The…
Marina Biotech, Inc. (OTCMKTS:MRNA) illustrated a similar run of events, as it reinvigorated its PR activity in the new year and shot upwards as it received a patent protection for one of its therapies. MRNA is back at $1.38, after it slumped for a while following a temporary peak at $1.70. Marina Biotech, Inc. (OTCMKTS:MRNA)…
Tech Analysis & Market News